1. Survival outcomes of minimally invasive surgery for early-staged cervical cancer: A retrospective study from a single surgeon in a single center
- Author
-
Jinjin Li, Xiaoxia Chang, Pujun Li, Xiping Ouyang, Lin Xiao, Xue Gong, and Junying Tang
- Subjects
medicine.medical_specialty ,RD1-811 ,Uterine Cervical Neoplasms ,Single Center ,Hysterectomy ,One surgeon ,03 medical and health sciences ,0302 clinical medicine ,Minimally invasive surgery ,medicine ,Humans ,Minimally Invasive Surgical Procedures ,Survival outcomes ,Stage (cooking) ,Neoplasm Staging ,Retrospective Studies ,Cervical cancer ,Surgeons ,business.industry ,Cancer ,Retrospective cohort study ,medicine.disease ,Lymphovascular ,Single surgeon ,Surgery ,030220 oncology & carcinogenesis ,Early-stage cervical cancer ,Invasive surgery ,030211 gastroenterology & hepatology ,Female ,Neoplasm Recurrence, Local ,business - Abstract
Summary Objective Recent studies have shown that minimally invasive surgery (MIS) is associated with a higher recurrence rate in patients with early-stage cervical cancer. In this study, we aim to report the survival outcomes of patients with early-stage cervical cancer who received MIS, performed in a single center by the same surgeon. Methods Eligible participants included patients with early-stage cervical cancer in stage IA1 with lymphovascular space invasion (LVSI+), IA2, and IB1. The surgeries were carried out by a single surgeon and survival outcomes of the 137 patients were evaluated retrospectively. Results The median follow-up time for the 137 patients was 53 (25–94) months, with the five-year disease-free survival (DFS) rate of 96.4% and the five-year overall survival (OS) rate of 96.8%. Among them, six (4.38%) patients relapsed and four (2.92%) of whom died. The five-year DFS rate was significantly higher in patients with tumor≤2 cm in size than in those with tumor >2 cm (P = 0.013), however, with no significant difference in the five-year OS rate (P = 0.219). Conclusion According to the existing literature and the results of this study, for MIS, the proficiency levels of a surgeon may be associated with survival outcomes of cancer patients. Tumor size may also be an important factor affecting survival outcomes of cervical cancer patients.
- Published
- 2022